APA (7th ed.) Citation

Brown, M. J., Williams, B., Morant, S. V., Webb, D. J., Caulfield, M. J., Cruickshank, J. K., . . . MacDonald, T. M. (2016). Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): A parallel-group, double-blind randomised phase 4 trial. The lancet. Diabetes & endocrinology, 4(2), 136. https://doi.org/10.1016/S2213-8587(15)00377-0

Chicago Style (17th ed.) Citation

Brown, Morris J., et al. "Effect of Amiloride, or Amiloride Plus Hydrochlorothiazide, Versus Hydrochlorothiazide on Glucose Tolerance and Blood Pressure (PATHWAY-3): A Parallel-group, Double-blind Randomised Phase 4 Trial." The Lancet. Diabetes & Endocrinology 4, no. 2 (2016): 136. https://doi.org/10.1016/S2213-8587(15)00377-0.

MLA (9th ed.) Citation

Brown, Morris J., et al. "Effect of Amiloride, or Amiloride Plus Hydrochlorothiazide, Versus Hydrochlorothiazide on Glucose Tolerance and Blood Pressure (PATHWAY-3): A Parallel-group, Double-blind Randomised Phase 4 Trial." The Lancet. Diabetes & Endocrinology, vol. 4, no. 2, 2016, p. 136, https://doi.org/10.1016/S2213-8587(15)00377-0.